Bone and cancer: the osteoncology
- PMID: 24133529
- PMCID: PMC3796999
Bone and cancer: the osteoncology
Abstract
In recent years clinicians have witnessed a radical change in the relationship between bone and cancer, with in particular an increase in bone metastases incidence due to an improvement of patients survival. Bone metastases are responsible for the high morbidity in cancer patients with a strong clinical impact. For all these reasons, efforts have been directed to this important field with the foundation of the osteoncology, a new scientific and clinical branch involved in the management of patients with bone cancer disease, including primary bone tumors and bone metastases. Another innovative and important osteoncology topic is the Cancer Treatment Induced Bone Loss (CTIBL) that is mainly caused by antitumoral treatment with bone resorption induction. The diagnostic and therapeutic options are described briefly in order to highlight the importance of the multidisciplinary approach in this new field.
Keywords: CTIBL; bone cancer; bone metastases.
References
-
- Muir MJ, Bhandari M, Dunlop RB. Common primary tumors of bone. Can J Diagn. 2001;(2):121–13.
-
- Orbach D, Glorion C, Mary P, et al. Malignant tumors of the locomotor apparatus in children: an intermediate prognosis. Rev Prat. 2007;57:1080–1086. - PubMed
-
- Marcove RC, Mike V, Hajack JV, et al. Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Joint Surg (Am) 1970;52:411–423. - PubMed
-
- Marulanda GA, Henderson ER, Johnson DA, et al. The advantages and disadvantages of amputation and limb-salvaging techniques for the treatment of osteosarcoma are reviewed. Orthopedicsurgery options for the treatment of primary osteosarcoma. Cancer Control. 2008;15:13–20. - PubMed
Publication types
LinkOut - more resources
Full Text Sources